Study to Evaluate Xtressé Gummy Supplement in Men With Androgenic Alopecia (NCT07637071)
A Multi-center, Randomized, Double-Blind, Placebo- Controlled Pilot Study to Evaluate the Efficacy and Safety of Xtressé™ Gummy-Based Nutraceutical Supplement in Men With Androgenic Alopecia
🩺 Plain-English Summary (8th-Grade Level)
The goal of this study is to determine if Xtresse' gummy is safe and may help regrow hair in men with androgenic alopecia (common pattern hair loss). Forty-eight participants will be randomly assigned to receive either Xtresse' active gummy or placebo. Neither staff not participant will know which treatment is given. The main aims of this trial are: 1. To confirm using photographic analysis, changes in the quality, volume, and thickness of hair. 2. To gauge patient satisfaction with hair changes and application process. 3. Monitor and report any adverse events associated with the daily intake of Xtressé Participants who qualify will complete 3 in-person visits. Participants will be given a 90-day supply of the gummies at visits 1 (after voluntary consent is given) and 2 to cover the 6-month study period. Photographs and scalp analysis will be performed at each visit to measure changes in hair volume, thickness, and growth.
Who can join: Review the eligibility criteria below.
Location: Advanced Dermatology & Cosmetic Surgery — Maitland, Florida
Age range: 18 Years to 65 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (2 Sites)
- Advanced Dermatology & Cosmetic Surgery — Maitland, Florida
- Advanced Dermatology & Cosmetic Surgery — Port Orange, Florida
📞 Contact the Study Coordinator
Phone: (321) 594-6851
Email: matt@xtresse.com
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Androgenic Alopecia
- Evaluating the Efficacy of Platelet-rich Plasma Therapy in the Treatment of Androgenic Alopecia — Winston-Salem, North Carolina
- Autologous Hair Follicle Secretome for Androgenic Alopecia (Single Site) — West Hollywood, California
- A Clinical Study to Evaluate the Efficacy and Safety of Ultra in Promoting Hair Regrowth — Glenview, Illinois
- Computer-Assisted Hair Restoration Study Using ARTAS System — Los Altos, California
- Androgenic Alopecia TH07 Clinical Trial — Vancouver, British Columbia
Explore by condition: All Androgenic Alopecia clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.